ArticleMedicine2025
Ultrasound-guided microwave ablation for primary hyperparathyroidism in an elderly patient with pancytopenia: A case report.
Article in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
rationalePrimary hyperparathyroidism (PHPT) is the third major endocrine disorder characterized by increased secretion of parathyroid hormone, with an incidence of up to 3% in elderly women. Although current guidelines consider parathyroidectomy to be the only definitive treatment, it is extremely risky for elderly women with numerous underlying conditions. However, hypercalcemia and other clinical symptoms caused by PHPT can seriously threaten the health and quality of life of patients. Therefore, it is very important to find a safe and effective minimally invasive alternative therapy. Hence, we report a case of ultrasound-guided microwave ablation (MWA) for PHPT in an elderly patient with pancytopenia. PATIENT CONCERNS: A 75-year-old female patient with pancytopenia was diagnosed with PHPT and was admitted for treatment due to her strong desire for treatment. DIAGNOSES: Imaging examination, laboratory examination and ultrasound-guided fine-needle aspiration cytology all led to a diagnosis of PHPT for the patient.
interventionsConsidering the advanced age of the patient, suffering from pancytopenia and other underlying disease, the surgical risk is high, so MWA was selected for this hospitalization. OUTCOMES: We found that after 6 months of treatment, the following 4 indicators of the patient returned to normal (parathyroid hormone, 66.9 pg/mL; ionic calcium, 1.19 mmol/L; serum total calcium, 2.28 mmol/L; phosphorus, 0.80 mmol/L). The lesion volume of the patient gradually decreased, and the reduction rate of lesion volume reached 70.3% by 6 months after ablation. There were no complications, and no parathyroid nodules regenerated during follow-up. LESSONS: Ultrasound-guided MWA represents a safe and effective therapeutic option for elderly patients with PHPT.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.